Jubilant Life Sciences Launches ‘JUBI-R’, Generic Version Of Remdesivir For COVID-19 Treatment
Drug firm Jubilant Life Sciences has launched JUBI-R the generic version of antiviral drug remdesivir in India for the treatment of COVID-19 patients. The injectable drug is priced at Rs…
Share